Mesoblast reported 118.92M in Debt for its fiscal semester ending in June of 2024.


Debt Change Date
Avita Medical AUD 45.98M 895K Dec/2024
Clinuvel Pharmaceuticals AUD 879.78K 189.09K Jun/2024
Cochlear AUD 246.6M 2.9M Dec/2024
CSL USD 11.96B 219M Dec/2024
Pacific Edge NZD 2.9M 425K Mar/2025
Paradigm Biopharmaceuticals AUD 181.4K 38.99K Dec/2024
PYC Therapeutics AUD 1.21M 96.02K Dec/2024
Ramsay Health Care AUD 11.26B 317.4M Dec/2024
Sonic Healthcare AUD 4.8B 282.9M Dec/2024
Starpharma Holdings AUD 2.48M 1.05M Dec/2024
Telix Pharmaceuticals AUD 581.45M 559.3M Dec/2024